Karyopharm Therapeutics I...

NASDAQ: KPTI · Real-Time Price · USD
5.96
1.31 (28.17%)
At close: Aug 15, 2025, 3:59 PM
5.60
-6.01%
After-hours: Aug 15, 2025, 07:58 PM EDT

Karyopharm Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.08 -0.69 -1.68 -3.89
PEG Ratio
0.02 0.02 -0.08 0.10
PS Ratio
0.57 0.68 1.77 2.30
PB Ratio
-0.44 -0.73 -16.71 -6.06
P/FCF Ratio
-0.65 -1.07 -1.86 -4.28
P/OCF Ratio
-0.65 -1.07 -1.86 -4.51
OCF/S Ratio
-0.88 -0.63 -0.95 -0.51
Debt / Equity Ratio
-1.05 -1.3 -10.75 -2.27
Quick Ratio
1.64 3.32 5.25 3.68
Current Ratio
1.70 3.37 5.31 3.74
Asset Turnover
0.88 0.61 0.44 0.69
Interest Coverage
-3.19 -5.44 -5.69 -3.77
Return on Equity
0.41 1.05 9.92 1.56
Return on Assets
-0.46 -0.6 -0.46 -0.41
Return on Invested Capital
-1.23 -0.73 -0.48 -0.42
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.96 0.97 0.97 0.98
Net Profit Margin
-0.53 -0.98 -1.05 -0.59
Pretax Profit Margin
-0.53 -0.98 -1.05 -0.59
Operating Profit Margin
-0.82 -0.89 -0.91 -0.47
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.27 -0.81 -0.89 -0.46